|
Roche’s Avastin remains most requested drug in UK’s cancer drugs fund
PMLiVE Completing the top five most requested drugs were Roche’s MabThera (rituximab), which had 5.3 per cent of all requests (about 572) and GlaxoSmithKline’s Tyverb (lapatinib), which had 5.2 per cent of all requests (about 561). The ten most commonly used … |
|
An Interview With Dr. Dan Peterson
ProHealth A new area I’m excited about is the cytokine blockers and the immune modulator rituximab, which has gotten lot of press. Hopefully, they will do a much larger rituximab study in the near future. My concern with rituximab is that I don’t know how to … |
Economic Times |
DIPP may seek information from DCGI to manufacture generic version of …
Economic Times Indian companies have already developed biological products such as rituximab and pegylated interferon. There are several manufacturers who have trastuzumab in the pipeline as well,” said Leena Menghaney of Medecins Sans Frontieres, an international … |
Emergent BioSolutions Reports Financial Results for Second Quarter and First …Wall Street Journal (press release)… otlertuzumab and rituximab in relapsed CLL patients; — Announced positive preclinical efficacy and pharmacokinetic data for ES414, a…
Azom.comUnderstanding Antibodies for Medical Treatments Via Molecular Weight …Azom.comTherapeutic recombinant antibodies, principally of the Immunoglobulin G isotype (IgG), account for a growing share of biopharmaceuticals, and a growing number of ap…
Obinutuzumab active in three types of lymphomaHealioThirty-eight patients had undergone prior treatment with rituximab (Rituxan, Genentech/Idec Pharmaceuticals) and 22 were rituximab refractory. Researchers assigned the patients to one of two regimens….
RESEARCH AND MARKETS: Global and Chinese Monoclonal Antibody Industry …4-traders (press release)Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprise, which possessed seven products sold in the market including Avastin, He…
BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 …PR Newswire (press release)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow m…
BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 …MarketWatch (press release)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow m…
Global & China Monoclonal Antibody Market Analysis and 2017 Forecasts in …PR Web (press release)Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprises, which possessed seven products sold in the market including Avasti…